跳至主導覽
跳至搜尋
跳過主要內容
澳門理工大學 首頁
English
中文
首頁
研究單位
研究成果
學術履歷
新聞/媒體
按專業知識、姓名或所屬機構搜尋
連絡專家
查看斯高帕斯 (Scopus) 概要
唐 海誼
Professor
Professor
,
Faculty of Health Sciences and Sports
電話
85993438
電子郵件
henrytong
mpu.edu
mo
h-index
3272
引文
26
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
1998 …
2024
每年研究成果
概覽
指紋
網路
研究成果
(85)
新聞/媒體
(48)
類似的個人檔案
(6)
指紋
查看啟用 HOI YEE TONG 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Chemistry
Acetonitrile
35%
Amino Acid
35%
Berberine
35%
Bergenin
35%
Bioassay
35%
Buffer Solution
48%
Carbamazepine
35%
Co Crystallization
39%
Crystal Engineering
35%
Crystal Morphology
62%
Crystal Structure
95%
Crystalline Material
35%
Crystallization Kinetics
35%
Cysteine
35%
Density Functional Theory
46%
Differential Scanning Calorimetry
82%
Differential Thermal Analysis
100%
Disodium Cromoglycate
35%
Energetics
47%
Enolates
35%
Excipient
44%
Fourier Transform Infrared Spectroscopy
49%
Gibbs Free Energy
29%
Interfacial Energy
42%
Inverse Gas Chromatography
25%
Leucine
35%
Melting Point
26%
Methanol
29%
Naringenin
35%
Oleanolic Acid
35%
Pharmaceutical Industry
68%
Quantum Mechanics
35%
Ribavirin
35%
Salicylic Acid
59%
Salmeterol Xinafoate
95%
Single Crystal X-Ray Diffraction
29%
Single Crystal X-Ray Diffraction
23%
Solubility Diagram
35%
Statistical Ensemble
35%
Structure
23%
Supercritical Fluid
71%
Tautomerization
35%
Thermoanalysis
91%
Thermogravimetric Analysis
26%
Thiol
35%
Unit Cell Parameter
32%
Ursolic Acid
35%
Virtual Screening
35%
Voriconazole
35%
X-Ray Diffraction
59%
Pharmacology, Toxicology and Pharmaceutical Science
4 Aminobenzamide
42%
Aristolochia
35%
Aristolochic Acid
35%
Autism
35%
Berberine
35%
Bergenin
35%
Bioassay
35%
Bioavailability
61%
Buffer
50%
Carbamazepine
35%
Cefaclor
35%
Cosmetics
35%
Crystal Engineering
35%
Crystallization
53%
Curcumin
93%
Differential Scanning Calorimetry
45%
Disease
44%
Dosage Forms
71%
Drug
35%
Drug Discovery
71%
Drug-Drug Interaction
35%
Excipient
89%
Fish Oil
35%
High Performance Liquid Chromatography
42%
Imiquimod
35%
Infection
47%
Isoniazid
42%
Itraconazole
35%
Microparticle
35%
Nanoparticle
35%
Naringenin
35%
Observational Study
35%
Oleanolic Acid
71%
Pharmaceutics
53%
Pharmacokinetics
35%
Phototoxicity
35%
Polyglactin
35%
Povidone
35%
Prostaglandin D2
35%
Psoriasis
76%
Pulmonary Drug Delivery
53%
Resveratrol
35%
Salicylic Acid
35%
Selective Serotonin Reuptake Inhibitor
35%
Structure Determination
35%
Tanshinone IIA
35%
Traditional Chinese Medicine
35%
Virtual Screening
35%
Voriconazole
35%
Warfarin
35%
